NEW YORK (Reuters Health) – Most domains of health-related quality of life in iron-deficient patients with chronic heart failure improve significantly after 4 weeks of treatment with intravenous…
NEW YORK (Reuters Health) – In a controlled study, clinicians didn’t see any benefit to treating patent ductus arteriosus (PDA) early (as soon as mild PDA symptoms appear)…
NEW YORK (Reuters Health) – Dual rather than mono antiplatelet therapy started soon after ischemic stroke reduces the risk of recurrence without a significant increase in risk of…
NEW YORK (Reuters Health) – In patients with atrial fibrillation undergoing radiofrequency catheter ablation, complication risks are higher with use of dabigatran for anticoagulation compared with uninterrupted warfarin,…
NEW YORK (Reuters Health) – Late lumen loss at 6 months is smaller with the Cre8 amphilimus-eluting stent than the Taxus paclitaxel-eluting stent in de novo percutaneous coronary…
NEW YORK (Reuters Health) – The benefits of preemptive percutaneous mitral commissurotomy (PMC) in asymptomatic patients with moderate mitral stenosis appear to outweigh the inherent risks of the…
NEW YORK (Reuters Health) – For prevention of contrast-induced nephropathy (CIN), volume supplementation with sodium chloride 0.9% for 24 hours was more effective than a 7-hour regimen of…
NEW YORK (Reuters Health) – A proximal balloon occlusion device provided better protection against cerebral emboli than a filter device during coronary artery stenting (CAS) in the first…
NEW YORK (Reuters Health) – Three cardiologists from China say intracoronary administration of a glycoprotein IIb/IIIa receptor inhibitor (GPI) “can be recommended as a preferred regimen” during primary…
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of…